Literature DB >> 2981966

Antigenic and biochemical analysis of gB of herpes simplex virus type 1 and type 2 and of cross-reacting glycoproteins induced by bovine mammillitis virus and equine herpesvirus type 1.

B W Snowden, P R Kinchington, K L Powell, I W Halliburton.   

Abstract

An antiserum was produced to the oligomeric form of glycoprotein B (gB) induced by herpes simplex virus type 1 (HSV-1) strain 17. This antiserum gave a single common precipitin line in agar gel immunodiffusion with HSV-1, HSV-2, bovine mammillitis virus (BMV) and equine herpesvirus type 1 (EHV-1). It also neutralized HSV-1, HSV-2 and BMV but not EHV-1. Absorption of the antiserum with excess HSV-2 or BMV antigen resulted in an HSV-1-specific neutralizing antiserum. In immunoprecipitation, two proteins, gB and pgB, were precipitated from HSV-1- and HSV-2-infected cells and at least three from BMV- and EHV-1-infected cells. Glycoprotein B and pgB of three HSV-1 and three HSV-2 strains and the corresponding antigenically related glycoproteins of BMV- and EHV-1-infected cells were labelled with 125I, digested with trypsin and the resulting peptides separated by two-dimensional thin-layer chromatography or high-pressure liquid chromatography. The resulting profiles were found to be almost identical, suggesting considerable structural conservation of the peptide backbone of the antigenically related glycoproteins of these four viruses.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981966     DOI: 10.1099/0022-1317-66-2-231

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  19 in total

1.  The simian herpesvirus SA8 homologue of the herpes simplex virus gB gene: mapping, sequencing, and comparison to the HSV gB.

Authors:  R Eberle; D Black
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

2.  Cross-reactivity between herpes simplex virus glycoprotein B and a 63,000-dalton varicella-zoster virus envelope glycoprotein.

Authors:  C M Edson; B A Hosler; R A Respess; D J Waters; D A Thorley-Lawson
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

3.  Epstein-Barr virus glycoprotein homologous to herpes simplex virus gB.

Authors:  M Gong; T Ooka; T Matsuo; E Kieff
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

4.  Conserved antigenic and functional domains on glycoprotein B of herpes simplex virus 1 and bovine herpesvirus 2. Brief report.

Authors:  F Conraths; M Ackermann; H Ludwig; G Pauli; L Pereira
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

5.  Cloned bovine cytolytic T cells recognize bovine herpes virus-1 in a genetically restricted, antigen-specific manner.

Authors:  G A Splitter; L Eskra; A F Abruzzini
Journal:  Immunology       Date:  1988-01       Impact factor: 7.397

6.  Compartment-specific immunolocalization of conserved epitopes of the glycoprotein gB of herpes simplex virus type 1 and bovine herpes virus type 2 in infected cells.

Authors:  S M Pietschmann; H R Gelderblom; G Pauli
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

7.  Assembly and processing of the disulfide-linked varicella-zoster virus glycoprotein gpII(140).

Authors:  E A Montalvo; C Grose
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

8.  The pseudorabies virus gII gene is closely related to the gB glycoprotein gene of herpes simplex virus.

Authors:  A K Robbins; D J Dorney; M W Wathen; M E Whealy; C Gold; R J Watson; L E Holland; S D Weed; M Levine; J C Glorioso
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

9.  Herpesvirus ICP18.5 and DNA-binding protein genes are conserved in equine herpesvirus-1.

Authors:  C W Bell; J M Whalley
Journal:  Virus Genes       Date:  1993-09       Impact factor: 2.332

10.  A comparison of T cell responses to glycoprotein B (gB-1) of herpes simplex virus type 1 and its non-glycosylated precursor protein, pgB-1.

Authors:  C A O'Donnell; W L Chan
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.